Neovasc Inc. (TSE:NVCN – Get Free Report)’s stock price rose 0.6% during trading on Monday . The company traded as high as C$40.15 and last traded at C$40.15. Approximately 399 shares were traded during trading, a decline of 81% from the average daily volume of 2,123 shares. The stock had previously closed at C$39.92.
Neovasc Trading Up 0.6 %
The stock has a market capitalization of C$110.81 million, a price-to-earnings ratio of -1.96 and a beta of 2.01. The business has a fifty day simple moving average of C$40.15. The company has a current ratio of 8.44, a quick ratio of 8.04 and a debt-to-equity ratio of 44.86.
Neovasc Company Profile
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.
Featured Stories
- Five stocks we like better than Neovasc
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- How to Calculate Stock Profit
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Why Invest in High-Yield Dividend Stocks?
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.
